Abiopharma

Integer Holdings Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea

ResMed Inc. Daily Stock Update

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Rosen Law Firm Urges Integer Holdings Corporation (NYSE: ITGR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS

Cycle Pharmaceuticals to Acquire Applied Therapeutics

Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference